Skip to main content

Nonprofit · EIN 83-1246927

CIVICA INC

Tax-exempt · LEHI, UT 84043

Financials

$50.7M$97M2023$65M$113.2M2024
Revenue Expenses · by fiscal year end
Financials of CIVICA INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$64,992,602$113,224,542-$48,231,940$283,067,991$303,721,065-$20,653,074
December 31, 2023990$50,668,299$96,953,261-$46,284,962$236,715,779$209,136,913$27,578,866
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$28,432,107
of which government grants
$233,550
Program service revenue
$5,439,790
Investment income
$2,226,750
Net income from sales of inventory
$28,893,955
Other revenue
$28,893,955

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$1,992,059
Other salaries and wages
$39,111,074
Salaries, compensation and benefits (total)
$49,384,379
Professional fundraising fees
$0
Legal fees
$762,527
Accounting fees
$218,954
Occupancy
$1,411,714
Travel
$1,302,042
Depreciation
$123,127
Program services (functional)
$87,342,285
Management and general (functional)
$25,882,257

Balance sheet and other

Total assets, start of year
$236,715,779
Total assets, end of year
$283,067,991
Total liabilities, end of year
$303,721,065
Net assets, end of year
-$20,653,074
Land, buildings and equipment
$192,965,156
Net assets without donor restrictions
-$120,653,074
Net assets with donor restrictions
$100,000,000
Gross receipts
$151,792,726
Employees
293
Volunteers
14
Year formed
2018
State of legal domicile
DE

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationFrom related orgsOther / benefits
NED MCCOYCHIEF EXECUTIVE OFFICER
Trustee or director, Officer
24$790,906$527,270$48,984
KRISTOPHER WEIDLINGCHIEF HUMAN RESOURCES
Highest-paid employee
36$796,605$88,512$65,526
EAMON FITZMAURICECHIEF FINANCIAL OFFICER
Officer
24$534,964$356,643$52,140
DONNA GULBINSKICHIEF QUALITY & REG AFFAIRS OFFICER
Highest-paid employee
28$621,572$266,388$55,759
JENNIFER SPALDINGCHIEF COMM'L OFFICER/GENERAL COUNSEL
Officer
26$583,770$314,337$31,196
DEBBI FORDCHIEF COMMUNICATIONS (THRU OCT '24)
Highest-paid employee
16$323,909$485,863$48,813
JAY BENSONCHIEF MFG & SUPPLY CHAIN OFFICER
Highest-paid employee
36$628,559$69,840$64,876
ALLAN COUKELLCHIEF GOVT. AFFAIRS/PUBLIC POLICY OFFICER
Highest-paid employee
30$406,420$135,474$64,653
DAN LILJENQUISTCHAIR
Trustee or director, Officer
2$0$0$0
DENNIS DAHLENDIRECTOR
Trustee or director
1$0$0$0
SHELLEY LYFORDDIRECTOR
Trustee or director
1$0$0$0
KATHLEEN SANFORDDIRECTOR
Trustee or director
1$0$0$0
ANDREA NODADIRECTOR
Trustee or director
1$0$0$0
ERIN ASPRECDIRECTOR
Trustee or director
1$0$0$0
WILLIAM RUTHERFORDDIRECTOR (THRU APRIL '24)
Trustee or director
1$0$0$0
9 more people on this return
NameTitleHours / weekCompensation
MICHAEL ROWEDIRECTOR (THRU AUG. '24)
Trustee or director
1$0
DREW HOBBYDIRECTOR
Trustee or director
1$0
DAN ROTHDIRECTOR
Trustee or director
1$0
HODA ASMARDIRECTOR
Trustee or director
1$0
MAIRIN MANCINODIRECTOR
Trustee or director
1$0
DAVID YODERDIRECTOR
Trustee or director
1$0
JOHN HACKETTDIRECTOR (FROM MAY '24)
Trustee or director
1$0
KEVIN SMITHDIRECTOR (FROM NOV. '24)
Trustee or director
1$0
CHRIS CLAGGDIRECTOR (FROM AUG. '24)
Trustee or director
1$0
990 for the year ended December 31, 2023: 23 people
NameTitleHours / weekCompensationFrom related orgsOther / benefits
NED MCCOYCHIEF EXECUTIVE OFFICER
Trustee or director, Officer
24$714,319$476,212$29,444
RUSSELL GALL CHIEF MFGSUPPLY CHAIN OFFICER (THRU 6/23)
Highest-paid employee
40$1,152,525$0$47,492
DEBBI FORDCHIEF COMMUNICATIONS
Highest-paid employee
16$348,482$522,724$47,768
DONNA GULBINSKICHIEF QUALITY & REGULATORY
Highest-paid employee
28$605,355$259,438$51,334
JENNIFER SPALDINGGENERAL COUNSEL
Officer
20$437,085$437,085$16,486
EAMON FITZMAURICECHIEF FINANCIAL OFFICER
Officer
24$466,939$311,293$81,389
KRISTOPHER WEIDLINGCHIEF HUMAN RESOURCES
Highest-paid employee
36$696,519$77,391$63,219
ALLAN COUKELLSENIOR VP PUBLIC POLICY
Officer
30$340,781$113,594$38,157
DAN LILJENQUISTCHAIR
Trustee or director, Officer
1$0$0$0
CARTER DREDGEDIRECTOR
Trustee or director
1$0$0$0
DENNIS DAHLENDIRECTOR
Trustee or director
1$0$0$0
SHELLEY LYFORDDIRECTOR
Trustee or director
1$0$0$0
KATHLEEN SANFORDDIRECTOR
Trustee or director
1$0$0$0
ANDREA NODADIRECTOR
Trustee or director
1$0$0$0
ERIN ASPRECDIRECTOR
Trustee or director
1$0$0$0
WILLIAM RUTHERFORDDIRECTOR
Trustee or director
1$0$0$0
MICHAEL ROWEDIRECTOR
Trustee or director
1$0$0$0
DREW HOBBYDIRECTOR
Trustee or director
1$0$0$0
DAN ROTHDIRECTOR
Trustee or director
1$0$0$0
HODA ASMARDIRECTOR
Trustee or director
1$0$0$0
MAIRIN MANCINODIRECTOR (FROM 12/31/23)
Trustee or director
1$0$0$0
MARTIN VANTRIESTEDIRECTOR
Trustee or director
1$0$0$0
BLAKE WILKERSONDIRECTOR
Trustee or director
1$0$0$0

Address and contacts

Address (IRS master file)
2912 W EXECUTIVE PKWY STE 325, LEHI, UT 84043-4622
In care of
% JENNIFER SPALDING
Principal officer (990 for 2024)
NED MCCOY, 2912 W EXECUTIVE PKWY STE 325, LEHI, UT 84043
Signed the 990
EAMON FITZMAURICE, CHIEF FINANCIAL OFFICER
Phone
(888) 304-0120
Return prepared by
EIDE BAILLY LLP

Mission

CIVICA'S MISSION IS TO ENHANCE AVAILABILITY AND AFFORDABILITY OF QUALITY GENERIC INJECTABLES FOR PATIENTS, ESPECIALLY HIGH NEEDS POPULATIONS, BY (1) ALLEVIATING DRUG SHORTAGES AND (2) PROVIDING THESE DRUGS AT A SUSTAINABLE AND AFFORDABLE LEVEL, BOTH VIA ITS MEMBER HOSPITAL SYSTEMS AS WELL AS NON-MEMBER ORGANIZATIONS INCLUDING NON-MEMBER COVERED ENTITIES LIKE 340B HOSPITALS AND ADDITIONALLY, GOVERNMENT ORGANIZATIONS INCLUDING VETERANS AFFAIRS AND DEPARTMENT OF DEFENSE.

990 for the year ended December 31, 2024

Program accomplishments

  • GENERIC DRUG DISTRIBUTIONDEVELOP AN OPEN AND GROWING NETWORK OF HOSPITALS TO EXPAND THE REACH OF CIVICA'S MISSION AND ITS BENEFITS TO BOTH MEMBERS AND NON-MEMBERS. ALLEVIATE SHORTAGES OF ESSENTIAL DRUG PRODUCTS AND STABILIZE PRICING BY SECURING AVAILABILITY FROM EXISTING MANUFACTURERS FOR THE BENEFIT OF PATIENTS SERVED BY THESE MEMBERS AND NON-MEMBER CUSTOMERS. CIVICA'S MAJOR ACCOMPLISHMENTS TO DATE INCLUDE THE FOLLOWING:(1) CONTINUED CUSTOMER GROWTH WITH 85 MILLION PATIENTS SERVED TO DATE. NEW CUSTOMERS ENROLLED INCLUDE NATIONWIDE NON-MEMBER 340B HOSPITALS THAT SERVE A DISPROPORTIONATE POPULATION OF HIGH-NEED PATIENTS, VETERANS AFFAIRS HOSPITALS, AND THE DEPARTMENT OF DEFENSE. (2) CONTINUED LAUNCH OF ESSENTIAL MEDICINES DEEMED IN SHORT SUPPLY PER THE FDA OR ASHP DRUG SHORTAGES LISTS.(3) ESTABLISHED AND MAINTAINED APPROXIMATELY 6 MONTHS OF FINISHED GOODS INVENTORY TO BUFFER ANY SUPPLY CHAIN SHOCKS TYPICALLY EXPERIENCED IN THE INDUSTRY FOR ESSENTIAL STERILE INJECTABLE MEDICINES. (4) SINGLE TRANSPARENT AFFORDABLE PRICING TO ALL MEMBERS AND NON-MEMBERS REGARDLESS OF MEMBERSHIP STATUS, SIZE OF THE HOSPITAL, VOLUME OF DRUGS PURCHASED FROM CIVICA OR RELATIONSHIP LONGEVITY WITH CIVICA.
    Expenses $36,894,776 · revenue $31,500,392
  • FILL - FINISH FACILITYTHE COVID-19 PANDEMIC, WHICH RESULTED IN A SPIKE IN DEMAND FOR MEDICATIONS IN HOSPITALS MANAGING SIGNIFICANT PATIENT SURGES, BROUGHT TO LIGHT THE DEPENDENCE OF THE UNITED STATES ON FOREIGN MANUFACTURERS OF GENERIC, ESSENTIAL, LIFE-SAVING MEDICATIONS; ESPECIALLY STERILE INJECTABLES. IN AN EFFORT TO ON-SHORE END-TO-END MANUFACTURING OF SUCH STERILE INJECTABLES, AND AS A NATIONAL SECURITY MEASURE, BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY ("BARDA"), A U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES ("HHS") GOVERNMENT OFFICE RESPONSIBLE FOR THE PROCUREMENT AND DEVELOPMENT OF MEDICAL COUNTERMEASURES, PRINCIPALLY AGAINST BIOTERRORISM, INCLUDING CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR THREATS, AS WELL AS PANDEMIC INFLUENZA AND EMERGING DISEASES, AWARDED CONTRACT NO. 75A50120C00092 ("PRIME CONTRACT") TO PHLOW CORP., ("PHLOW") TO CREATE END-TO-END MANUFACTURING IN THE UNITED STATES. PHLOW IS A DELAWARE PUBLIC BENEFIT CORPORATION ENGAGED IN THE BUSINESS OF THE RESEARCH, DEVELOPMENT, AND COMMERCIALIZATION OF PHARMACEUTICAL PRODUCTS. PHLOW SUBCONTRACTED CERTAIN OF ITS OBLIGATIONS UNDER THE PRIME CONTRACT TO CIVICA WHEREBY CIVICA WILL QUALIFY, DESIGN, BUILD, EQUIP, OPERATE, AND OWN A 120,000 SQUARE FOOT, TWO-STORY, CGMP COMPLIANT ASEPTIC FILL-FINISH FACILITY ("FILL-FINISH FACILITY"), TO BE FUNDED, AT LEAST PARTIALLY, WITH $100,000,000 PROVIDED BY BARDA. THE FILL-FINISH FACILITY WILL BE CAPABLE OF, AMONG OTHER THINGS, PROVIDING AT LEAST 90 MILLION ASEPTIC OR TERMINALLY STERILIZED VIALS AND 50 MILLION PRE-FILLED SYRINGES ANNUALLY. THE FACILITY IS COMPLETE ALONG WITH SUBMISSION OF THE APPLICATION FOR THE APPROVAL OF THE FACILITY. THE FIRST PRODUCTS, AND COMMENCEMENT OF COMMERCIAL PRODUCTION, ARE ANTICIPATED IN 2026. CIVICA INTENDS TO USE THE FILL-FINISH FACILITY TO, AMONG OTHER THINGS, (1) MANUFACTURE STERILE INJECTABLES IN FURTHERANCE OF ITS GENERIC DRUG DISTRIBUTION PROGRAM IDENTIFIED PREVIOUSLY, (2) SUPPORT THE NEEDS OF THE U.S. GOVERNMENT FOR ANY FUTURE PANDEMICS OR SIMILAR EMERGENCIES, (3) PROVIDE SURPLUS MANUFACTURING CAPACITY TO OTHER U.S.-BASED STERILE INJECTABLE MANUFACTURERS WHO SERVE THE NEEDS OF THE COUNTRY FOR SHORTAGE MEDICATIONS, AND (4) PRODUCE LOW-COST INSULIN FOR THE US MARKET TO ALLEVIATE DISTRESS THAT AFFORDABILITY CHALLENGES CAUSE TO PATIENTS.
    Expenses $48,851,416
  • OUT-PATIENT SERVICESON OR ABOUT JANUARY 23, 2020, CIVICA ANNOUNCED AN ARRANGEMENT WITH THE BLUE CROSS BLUE SHIELD ASSOCIATION ("BCBSA") AND A NUMBER OF INDEPENDENT BLUE CROSS AND BLUE SHIELD COMPANIES ("BCBSS; WITH BCBSA, THE "BLUES"). THE ARRANGEMENT INVOLVED THE CREATION OF A NEW BUSINESS ENTITY, CIVICASCRIPT, DEDICATED TO LOWERING THE COST OF SELECT OUTPATIENT GENERIC MEDICATIONS IN RESPONSE TO THE IMPACT OF HIGH DRUG COSTS ON THE HEALTH OF AMERICANS AND THE OVERALL AFFORDABILITY OF HEALTH CARE BY DEVELOPING AND MANUFACTURING GENERIC OUTPATIENT MEDICATIONS. IN FURTHERANCE OF THE ARRANGEMENT, ON OR ABOUT JANUARY 27, 2020, CIVICA CAUSED CIVICASCRIPT TO BE ORGANIZED AS A DELAWARE LIMITED LIABILITY COMPANY TO PROMOTE PUBLIC BENEFITS, INCLUDING PROMOTION OF AVAILABILITY OF AFFORDABLE OUTPATIENT GENERIC DRUGS. CIVICASCRIPT, A STATUTORY PUBLIC BENEFIT LLC UNDER DELAWARE LAW , IS TREATED AS A CORPORATION FOR U.S FEDERAL TAX PURPOSES. HOWEVER, CIVICASCRIPT HAS APPLIED FOR TAX-EXEMPT STATUS AS A PUBLIC CHARITY. IF APPROVED, THE EFFECTIVE DATE OF EXEMPTION WOULD BE SEPTEMBER 1, 2023.BASED ON MARKET AND OTHER RESEARCH BY CIVICASCRIPT, AS APPROVED BY ITS BOARD, CIVICASCRIPT IS CURRENTLY IN THE PROCESS OF DEVELOPING GENERIC VERSIONS OF CERTAIN MEDICATIONS. IN ALIGNMENT WITH CIVICASCRIPT'S FOUNDING MISSION, THESE GENERIC MEDICATIONS WILL BE SOLD TO CIVICA-AFFILIATED HOSPITALS, ALL "340B HOSPITALS,", ALL VETERANS AFFAIRS ("VA") HOSPITALS, AND TO RETAILERS.CIVICA, INC. ENTERED INTO A SERVICES AGREEMENT EFFECTIVE SEPTEMBER 1, 2020, WITH CIVICASCRIPT. CIVICA, INC. IS A MEMBER OF CIVICASCRIPT AND A RELATED PARTY. THE PROVISIONS OF THIS AGREEMENT ALLOW FOR CIVICA, INC. TO PROVIDE CIVICASCRIPT WITH ADMINISTRATIVE SUPPORT AND OTHER SERVICES TO ENABLE THE PUBLIC TO REALIZE THE BENEFITS CIVICASCRIPT INTENDS TO PROVIDE. THESE SERVICES INCLUDE EXECUTIVE MANAGEMENT SERVICES, PROFESSIONAL ASSISTANCE, RISK MANAGEMENT, QUALITY & REGULATORY SUPPORT AND OVERSIGHT, FINANCE & ACCOUNTING SERVICES, AND DATA ANALYTICS.
    Expenses $1,210,295 · revenue $1,210,295
  • CIVICA ENTERED INTO A MASTER SERVICE AGREEMENT WITH A US BASED FOR PROFIT PHARMA COMPANY ON APRIL 18, 2024, TO SUPPORT THE GLOBAL SUPPLY OF (FILL AND FINISH) STERILE INJECTABLE MEDICATIONS WHICH WERE ON THE FDA DRUG SHORTAGE LIST, AND FOR WHICH THE PARTNERING COMPANY IS DELAYING LAUNCHES IN MARKETS DUE TO PRODUCTION CAPACITY CONSTRAINTS. PURSUANT TO WORK ORDERS UNDER THIS AGREEMENT, CIVICA IS PRODUCING BOTH PRE-FILLED SYRINGES AND CARTRIDGES FOR ASSEMBLY INTO INJECTION DEVICES. THIS PROGRAM ADVANCES CIVICA'S MISSION TO INCREASE ACCESS TO ESSENTIAL, AFFORDABLE MEDICATIONS BY SUPPORTING A LOW-COST, RELIABLE PRODUCTION OF HIGH-DEMAND, CLINICALLY IMPORTANT TREATMENTS FOR PATIENTS.
    Expenses $385,798 · revenue $1,623,058

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
83-1246927
Tax-exempt status
501(c)(4): Social welfare organization
Exempt since
2020
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$283,067,991
Income (IRS master file)
$151,792,726

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$64,992,602$113,224,542$283,067,991IRS
990December 2023$50,668,299$96,953,261$236,715,779XML
990December 2022$43,953,660$65,165,140$233,818,442IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 83-1246927).

Questions about CIVICA INC

What is the EIN of CIVICA INC?
The employer identification number (EIN) of CIVICA INC is 83-1246927.
Is CIVICA INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(4) since 2020.
Which annual return does CIVICA INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CIVICA INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CIVICA INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of CIVICA INC?
The 990 for the year ended December 31, 2024 names NED MCCOY.
Who are the officers and directors of CIVICA INC?
The 990 for the year ended December 31, 2024 lists 24 people; 8 received compensation from the organization, the highest $790,906 (NED MCCOY, CHIEF EXECUTIVE OFFICER).
How much revenue does CIVICA INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $64,992,602, expenses of $113,224,542 and total assets of $283,067,991 at year end.

Other nonprofits in LEHI

All nonprofits in LEHI · Utah